Almirall, a global pharmaceutical company dedicated to medical dermatology, today announced the launch of “The Hive”, a novel scientific research hub located at its R&D centre in Barcelona, Spain. The ...

Celerion, a global leader in early clinical research, is proud to announce its commitment to the Science Based Targets Initiative (SBTi), reinforcing its dedication to sustainable corporate climate ...

Independent Data Safety Monitoring Board declared dose level 2 as safe and recommended escalation to final dose level 3Munich, ...

Pharma Contract Manufacturing 2025 is taking place in Berlin next March (26-27th). Download the event details here: Ahead of ...

Elsevier, a global leader in information and analytics, and Enamine, a global leader in supplying small molecules and early drug discovery services, have announced a partnership to integrate Enamine’s ...

IHH Healthcare, one of the world’s largest private healthcare groups, is harnessing its unique global reach to deliver cutting-edge healthcare while championing sustainability. Hospitals are ...

Ivan Wall, Professor of Regenerative Medicine at the University of Birmingham, and co-director of Resilience, the UK’s Medicines Manufacturing Skills Centre of Excellence, says the use of VR and AR ...

VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment from Ampersand Capital Partners (“Ampersand”), a private ...

Synaffix B.V., a Lonza company (SIX:LONN) focused on commercializing its clinical-stage bioconjugation platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class ...

Antag Therapeutics, a next-generation biopharmaceutical company pioneering novel treatments for obesity, today announced the closing of an €80 million Series A financing. The round was led by Versant ...

European health technology (HealthTech) is at a critical crossroad. Despite groundbreaking research, a thriving startup scene and ambitious talent, the sector struggles to translate innovation into ...

Diagnostics is pleased to announce the completion of a €30 million Series D funding round, led by Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science. This investment will ...